Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Videos Gallery
  • Implementing AlphaLISA™ SureFire® Ultra™ Technology - video
Video Asset Illuminator

Implementing AlphaLISA™ SureFire® Ultra™ Technology - video

Utilize this video to explore the simplicity and accuracy of AlphaLISA™ SureFire® Ultra™ immunoassays for your drug discovery research.
Share:
Share via Email Share on Facebook Share on LinkedIn Share on X
Related videos
Antibody drug conjugates: a novel approach and evaluation of efficacy and potency
Biologics
Biologics
Cancer Research Solutions
Cancer Research Solutions

Antibody drug conjugates: a novel approach and evaluation of efficacy and potency
Optimizing biotherapeutic cell lines for continuous manufacturing
Biologics
Biologics
Drug Development
Drug Development

Optimizing biotherapeutic cell lines for continuous manufacturing
Phenotypic screening and tools for 3D multicellular spheroid analysis in modern medicine development
Cell and Gene Therapy
Cell and Gene Therapy
Biologics
Biologics

Phenotypic screening and tools for 3D multicellular spheroid analysis in modern medicine development
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.